CBD

Comparative Pharmacokinetics and Safety of Cannabidiol in a Powder Formulation, CBtru®, vs an Oil-Based Formulation, Epidyolex®, Under Fasted and Fed Conditions in Healthy Participants: A Randomized Open-Label Cross-Over Phase I Study

2026

Comparative Pharmacokinetics and Safety of Cannabidiol in a Powder Formulation, CBtru®, vs an Oil-Based Formulation, Epidyolex®, Under Fasted and Fed Conditions in Healthy Participants: A Randomized Open-Label Cross-Over Phase I Study

Ingredient: CBD

Indication: Neurological, Pain, and Psychiatric Disorders

Trial Type: Clinical Trial

Sponsor: DSM Nutritional Products AG

Journal: Springer Nature Link

Authors: Josh Baisley, Bernd Mussler, Adam Kuttenkeuler, Anu Manderna, Jun Wang

Safety Study of Cannabidiol Products in Healthy Dogs

2024

Safety Study of Cannabidiol Products in Healthy Dogs

Ingredient: CBD

Indication: Toxicology

Trial Type: Preclinical Studies

Sponsor: National Animal Supplement Council (NASC)

Journal: Frontiers in Veterinary Science

Authors: Margitta Dziwenka, Kaiti Valm, Jennifer Kovacs-Nolan

Toxicological safety assessment of HempChoice® hemp oil extract; a proprietary extract consisting of a high concentration of cannabidiol (CBD) in addition to other phytocannabinoids and terpenes derived from CannabissativaL

2023

Toxicological safety assessment of HempChoice® hemp oil extract; a proprietary extract consisting of a high concentration of cannabidiol (CBD) in addition to other phytocannabinoids and terpenes derived from CannabissativaL

Ingredient: CBD,Hemp oil

Indication: Preclinical Toxicology

Trial Type: Toxicology

Sponsor: Geocann

Journal: Heliyon

Authors: Margitta Dziwenka